Overview

Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse

Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
We are testing to see if Galantamine, a learning enhancing medication, will help methadone maintained cocaine abusers with their learning and memory specific to CBT using an innovative CBT computer program.
Phase:
Phase 2
Details
Lead Sponsor:
Yale University
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Cocaine
Galantamine
Methadone